News and Trends 2 Jul 2019 Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms of the metabolic syndrome including insulin resistance and high blood cholesterol levels in overweight volunteers… July 2, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 11 Jan 2023 Drug repurposing emerges as viable option for rare disease treatment With few options available for the treatment of rare diseases, the practice of drug repurposing has gained traction as an effective strategy. With genome sequencing revealing new rare diseases, it… January 11, 2023 - 7 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Interview 4 Sep 2019 Overcoming Clinical Setbacks to Fight Insect-Borne Diseases …biotech company weathered phase III failures to develop vaccines for neglected diseases. Once confined to the less developed regions of the world, many insect-borne diseases such as Lyme disease and… September 4, 2019 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023 Vaxxinity making vaccines to change the world …to tackle hard-to-treat diseases. 6 new vaccines being developed for difficult-to-treat diseases (Labiotech.eu) Is a vaccine for Parkinson’s disease possible? (Labiotech.eu) Migraines: a new vaccine frontier beyond infectious diseases (Labiotech.eu)… December 15, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Reports 30 Jul 2020 Current and Emerging Therapeutic Approaches for Autoimmune Diseases …five autoimmune diseases and determine the different inflammatory pathways that can be targeted for the treatment of cancer and autoimmune diseases alike. GIVE ME THE GUIDE! Images via E. Resko… July 30, 2020 - 3 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2023 JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases …several achievements and advances in technology over the past few years, the pathophysiology of neurodegenerative diseases remains elusive. Recent studies show that diseases are complex and multifactorial, presenting barriers to… January 12, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2021 The Billion-Euro European Biotech Companies in 2022 …on a number of target diseases, including insomnia, hypertension, and rare and autoimmune diseases. In April 2020, Idorsia’s share price went up 14% after the company published positive results for… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2025 Six key obesity deals in 2025 …diabetes, and other cardiometabolic diseases. The companies’ initial focus involves commencing four development programmes for potential small molecule therapies directed to one or more select G protein-coupled receptor (GPCR) targets, including the GLP-1, GIP, and… November 21, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2025 AstraZeneca bets on Asia: a surge of deals in March amid fraud probe …macrocyclic peptide drug research and development platform, which is designed to create drugs that could potentially treat chronic diseases, including rare, autoimmune, and metabolic diseases. Macrocyclic peptides are peptides –… March 31, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Opinion 25 Oct 2023 Microbiome: are we ready for third generation live biotherapeutics? …(GI) infections and conditions, to boosting the potency of immuno-oncology treatments and perhaps in the future, the treatment of central nervous system (CNS) and metabolic diseases. It’s not been an… October 25, 2023 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Nov 2022 The hottest private biotech companies in Canada …rare metabolic diseases and conditions in the central nervous system. In 2021, Deep Genomics raised one of Canada’s biggest biotech Series C rounds, bagging $180 million. With the help of… November 17, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Feb 2023 AI boosts genome editing …the foreseeable future it will be possible to use prime editing to repair the DNA mutations of common inherited diseases such as sickle cell anemia, cystic fibrosis or metabolic diseases…. February 3, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email